You are here
- Home
- Lung Cancer
Lung Cancer
- PD-1 inhibitor plus chemotherapy versus bevacizumab plus chemotherapy in patients with advanced non-squamous non-small-cell lung cancer: a pooled analysis of three randomised trialsXiangjiao Meng, Yu Chen, Ligang Xing, Xinchao Liu, Kaikai Zhao, Liyang Jiang, Li Zhang, Caicun Zhou, Jinming YuBMJ Open Respiratory Research Sep 2022, 9 (1) e001294; DOI: 10.1136/bmjresp-2022-001294
- Cone beam CT-guided navigation bronchoscopy: a cost-effective alternative to CT-guided transthoracic biopsy for diagnosis of peripheral pulmonary nodulesStephan E P Kops, Roel L J Verhoeven, Robin J Vermeulen, Maroeska M Rovers, Erik H F M van der Heijden, Tim M GoversBMJ Open Respiratory Research Sep 2022, 9 (1) e001280; DOI: 10.1136/bmjresp-2022-001280
- Regional single-queue scheduling platform for specialist diagnostics in the lung cancer pathway: accelerating cancer recovery from the COVID-19 pandemicMatthew Evison, David Shackley, Lisa Galligan-DawsonBMJ Open Respiratory Research Jul 2022, 9 (1) e001321; DOI: 10.1136/bmjresp-2022-001321
- Postoperative cerebral infarction risk is related to lobectomy site in lung cancer: a retrospective cohort study of nationwide data in JapanNatsumasa Nishizawa, Makoto Okawara, Masataka Mori, Yoshihisa Fujino, Shinya Matsuda, Kiyohide Fushimi, Fumihiro TanakaBMJ Open Respiratory Research Jul 2022, 9 (1) e001327; DOI: 10.1136/bmjresp-2022-001327
- Lung cancer in recipients after lung transplant: single-centre experience and literature reviewBilal Haider Lashari, Robert J Vender, Derlis Christian Fleitas-Sosa, Tejas Sinha, Gerard J CrinerBMJ Open Respiratory Research Apr 2022, 9 (1) e001194; DOI: 10.1136/bmjresp-2021-001194
- Diagnostic value and safety of thoracoscopic pleural biopsies in pleural exudative effusions of unknown origin, including follow-upEvan Patrick Deschuyteneer, Tom De KeukeleireBMJ Open Respiratory Research Mar 2022, 9 (1) e001161; DOI: 10.1136/bmjresp-2021-001161
- Immediate smoking cessation support versus usual care in smokers attending a targeted lung health check: the QuLIT trialSara C Buttery, Parris Williams, Rebecca Mweseli, Keir Elmslie James Philip, Ahmed Sadaka, Emily Catharine Bartlett, Anand Devaraj, Samuel V Kemp, Jamie Addis, Jane Derbyshire, Michelle Chen, Katie Morris, Anthony Laverty, Nicholas S HopkinsonBMJ Open Respiratory Research Feb 2022, 9 (1) e001030; DOI: 10.1136/bmjresp-2021-001030
- Application of liquid biopsy-based targeted capture sequencing analysis to improve the precision treatment of non-small cell lung cancer by tyrosine kinase inhibitorsLei Zhang, John Coffin, Kim Formenti, Quincy Chu, Iyare IzevbayeBMJ Open Respiratory Research Jan 2022, 9 (1) e001154; DOI: 10.1136/bmjresp-2021-001154
- Malignant pleural mesothelioma patients’ experience by gender: findings from a cross-sectional UK-national questionnaireMichaela Senek, Steve Robertson, Liz Darlison, Lorraine Creech, Angela TodBMJ Open Respiratory Research Jan 2022, 9 (1) e001050; DOI: 10.1136/bmjresp-2021-001050
- Effect of a postoperative home-based exercise and self-management programme on physical function in people with lung cancer (CAPACITY): protocol for a randomised controlled trialCatherine L Granger, Lara Edbrooke, Phillip Antippa, Gavin Wright, Christine F McDonald, Karen E Lamb, Louis Irving, Meinir Krishnasamy, Shaza Abo, Georgina A Whish-Wilson, Dominic Truong, Linda Denehy, Selina M ParryBMJ Open Respiratory Research Jan 2022, 9 (1) e001189; DOI: 10.1136/bmjresp-2021-001189
Pages
- BMJ Open Respiratory Research
- Cough (3)
- Critical care (8)
- Cystic fibrosis (3)
- Lung cancer (9)
- Sleep (2)
- Thoracic surgery (1)
- Tuberculosis (2)